Gabapentin is an anticonvulsant that is used to treat certain types of epilepsy. It is also used to treat neuropathic pain, a type of pain or altered sensation caused by damage to the nerves. Gabapentin is successfully being used to treat skin conditions associated with pain and/or pruritus (itch) of neuropathic origin.
What is gabapentin used for?
Gabapentin is proving to be useful in reducing the symptoms of pain and/or unpleasant sensation caused by the following skin conditions:
- Pruritus (itch)
- in patients on haemodialysis (renal itch)
- in patients with brachioradial pruritus
- pruritus of unknown origin
- Post-herpetic neuralgia (see shingles)
Pain and/or pruritus arising from these conditions are defined as sympathetically maintained pain (SMP). The pain is usually described as having a burning sensation and is often in response to stimuli that does not ordinarily cause pain. This pain and pruritus originates from the nervous system.
The use of gabapentin for neuropathic pain/pruritus is recommended only in patients over 18 years of age. The starting dose is 900mg/day (given as 300mg 3 times daily) and increased if necessary based on response. The maximum daily dose is 3600mg.
Dosage may need to be adjusted in those with impaired renal function. Patients on haemodialysis should start on a loading dose of 300-400mg, followed by 200-300mg after each 4 hours of haemodialysis.
The side effects of gabapentin include:
- dry mouth
- unsteadiness, reduced co-ordination or slowed reaction
- constipation, diarrhoea
- peripheral oedema (swelling around the ankles)
- dizziness, confusion, loss of concentration
- weight gain
- changes in appetite
- nausea, vomiting, indigestion.
See your doctor if these effects occur and are of concern to you. Patients over the age of 65 years have an increased chance of getting side effects.
On DermNet NZ:
Books about skin diseases:
See the DermNet NZ bookstore
The New Zealand approved datasheet is the official source of information for this prescription medicine, including approved uses and risk information. Check the New Zealand datasheet on the Medsafe website.